Cargando…

Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside

Traumatic brain injury (TBI) is one of the leading causes of morbidity and mortality. Consequences vary from mild cognitive impairment to death and, no matter the severity of subsequent sequelae, it represents a high burden for affected patients and for the health care system. Brain trauma can cause...

Descripción completa

Detalles Bibliográficos
Autores principales: Baracaldo-Santamaría, Daniela, Ariza-Salamanca, Daniel Felipe, Corrales-Hernández, María Gabriela, Pachón-Londoño, Maria José, Hernandez-Duarte, Isabella, Calderon-Ospina, Carlos-Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781803/
https://www.ncbi.nlm.nih.gov/pubmed/35057048
http://dx.doi.org/10.3390/pharmaceutics14010152
_version_ 1784638167170678784
author Baracaldo-Santamaría, Daniela
Ariza-Salamanca, Daniel Felipe
Corrales-Hernández, María Gabriela
Pachón-Londoño, Maria José
Hernandez-Duarte, Isabella
Calderon-Ospina, Carlos-Alberto
author_facet Baracaldo-Santamaría, Daniela
Ariza-Salamanca, Daniel Felipe
Corrales-Hernández, María Gabriela
Pachón-Londoño, Maria José
Hernandez-Duarte, Isabella
Calderon-Ospina, Carlos-Alberto
author_sort Baracaldo-Santamaría, Daniela
collection PubMed
description Traumatic brain injury (TBI) is one of the leading causes of morbidity and mortality. Consequences vary from mild cognitive impairment to death and, no matter the severity of subsequent sequelae, it represents a high burden for affected patients and for the health care system. Brain trauma can cause neuronal death through mechanical forces that disrupt cell architecture, and other secondary consequences through mechanisms such as inflammation, oxidative stress, programmed cell death, and, most importantly, excitotoxicity. This review aims to provide a comprehensive understanding of the many classical and novel pathways implicated in tissue damage following TBI. We summarize the preclinical evidence of potential therapeutic interventions and describe the available clinical evaluation of novel drug targets such as vitamin B12 and ifenprodil, among others.
format Online
Article
Text
id pubmed-8781803
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87818032022-01-22 Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside Baracaldo-Santamaría, Daniela Ariza-Salamanca, Daniel Felipe Corrales-Hernández, María Gabriela Pachón-Londoño, Maria José Hernandez-Duarte, Isabella Calderon-Ospina, Carlos-Alberto Pharmaceutics Review Traumatic brain injury (TBI) is one of the leading causes of morbidity and mortality. Consequences vary from mild cognitive impairment to death and, no matter the severity of subsequent sequelae, it represents a high burden for affected patients and for the health care system. Brain trauma can cause neuronal death through mechanical forces that disrupt cell architecture, and other secondary consequences through mechanisms such as inflammation, oxidative stress, programmed cell death, and, most importantly, excitotoxicity. This review aims to provide a comprehensive understanding of the many classical and novel pathways implicated in tissue damage following TBI. We summarize the preclinical evidence of potential therapeutic interventions and describe the available clinical evaluation of novel drug targets such as vitamin B12 and ifenprodil, among others. MDPI 2022-01-08 /pmc/articles/PMC8781803/ /pubmed/35057048 http://dx.doi.org/10.3390/pharmaceutics14010152 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Baracaldo-Santamaría, Daniela
Ariza-Salamanca, Daniel Felipe
Corrales-Hernández, María Gabriela
Pachón-Londoño, Maria José
Hernandez-Duarte, Isabella
Calderon-Ospina, Carlos-Alberto
Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside
title Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside
title_full Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside
title_fullStr Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside
title_full_unstemmed Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside
title_short Revisiting Excitotoxicity in Traumatic Brain Injury: From Bench to Bedside
title_sort revisiting excitotoxicity in traumatic brain injury: from bench to bedside
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781803/
https://www.ncbi.nlm.nih.gov/pubmed/35057048
http://dx.doi.org/10.3390/pharmaceutics14010152
work_keys_str_mv AT baracaldosantamariadaniela revisitingexcitotoxicityintraumaticbraininjuryfrombenchtobedside
AT arizasalamancadanielfelipe revisitingexcitotoxicityintraumaticbraininjuryfrombenchtobedside
AT corraleshernandezmariagabriela revisitingexcitotoxicityintraumaticbraininjuryfrombenchtobedside
AT pachonlondonomariajose revisitingexcitotoxicityintraumaticbraininjuryfrombenchtobedside
AT hernandezduarteisabella revisitingexcitotoxicityintraumaticbraininjuryfrombenchtobedside
AT calderonospinacarlosalberto revisitingexcitotoxicityintraumaticbraininjuryfrombenchtobedside